These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan tin miners in China. Qiao YL, Tockman MS, Li L, Erozan YS, Yao SX, Barrett MJ, Zhou WH, Giffen CA, Luo XC, Taylor PR. Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):893-900. PubMed ID: 9367062 [Abstract] [Full Text] [Related]
3. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX. Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620 [Abstract] [Full Text] [Related]
8. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1. Fujimoto N, Sueoka N, Sueoka E, Okabe S, Suganuma M, Harada M, Fujiki H. Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004 [Abstract] [Full Text] [Related]
9. [Detection of oncogenic mutations in sputum and its diagnostic value of lung cancer]. Wang L, Wang G, Xia X. Zhonghua Jie He He Hu Xi Za Zhi; 1998 Apr; 21(4):236-9. PubMed ID: 11326973 [Abstract] [Full Text] [Related]
10. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Sueoka E, Sueoka N, Iwanaga K, Sato A, Suga K, Hayashi S, Nagasawa K, Nakachi K. Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973 [Abstract] [Full Text] [Related]
11. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention. Wiest JS, Franklin WA, Drabkin H, Gemmill R, Sidransky D, Anderson MW. J Cell Biochem Suppl; 1997 Apr; 28-29():64-73. PubMed ID: 9589350 [Abstract] [Full Text] [Related]